56
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Tailored antihypertensive drug therapy prescribed to older women attenuates circulating levels of interleukin-6 and tumor necrosis factor-α

, , , , , & show all
Pages 209-215 | Published online: 09 Jan 2015

References

  • ChengZJVapaataloHMervaalaEAngiotensin II and vascular inflammationMed Sci Monit2005116RA194RA20515917731
  • SuzukiYRuiz-OrtegaMGomez-GuerreroCTominoYEgidoJAngiotensin II, the immune system and renal diseases: another road for RAS?Nephrol Dial Transplant20031881423142612897073
  • GageJRFonarowGHamiltonMWidawskiMMartínez-MazaOVredevoeDLBeta blocker and angiotensin-converting enzyme inhibitor therapy is associated with decreased Th1/Th2 cytokine ratios and inflammatory cytokine production in patients with chronic heart failureNeuroimmunomodulation200411317318015067208
  • RosensonRSModulating atherosclerosis through inhibition or blockade of angiotensinClin Cardiol200326730531112862295
  • RosensonRSNew approaches in the intensive management of cardiovascular risk in the metabolic syndromeCurr Probl Cardiol200530524127915829899
  • SteenVTargeted therapy for systemic sclerosisAutoimmun Rev20065212212416431341
  • ZhangXLiZZLiuDFXuXMeiZCShenWAngiotensin-converting enzyme inhibitors improve hepatic steatosis by modulating expression of tumour necrosis factor-alpha, interleukin-6 and adiponec-tin receptor-2 in rats with type 2 diabetesClin Exp Pharmacol Physiol200936763163619076162
  • HagiwaraSIwasakaHMatumotoSHidakaSNoguchiTEffects of an angiotensin-converting enzyme inhibitor on the inflammatory response in in vivo and in vitro modelsCrit Care Med200937262663319114890
  • FlammerAJSudanoIHermannFAngiotensin-converting enzyme inhibition improves vascular function in rheumatoid arthritisCirculation2008117172262226918427133
  • Sanz-RosaDOubiñaMPCedielEEffect of AT1 receptor antagonism on vascular and circulating inflammatory mediators in SHR: role of NF-kappaB/IkappaB systemAm J Physiol Heart Circ Physiol20052881H111H11515308481
  • VerhoeckxKCGaspariMBijlsmaSIn search of secreted protein biomarkers for the anti-inflammatory effect of beta2-adrenergic receptor agonists: application of DIGE technology in combination with multivariate and univariate data analysis toolsJ Proteome Res2005462015202316335946
  • IzeboudCAMonshouwerMvan MiertASWitkampRFThe beta-adrenoceptor agonist clenbuterol is a potent inhibitor of the LPS-induced production of TNF-alpha and IL-6 in vitro and in vivoInflamm Res199948949750210522805
  • AcklandGLYaoSTRudigerACardioprotection, attenuated systemic inflammation, and survival benefit of beta1-adrenoceptor blockade in severe sepsis in ratsCrit Care Med201038238839419829100
  • FranceschiCCapriMMontiDInflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humansMech Ageing Dev200712819210517116321
  • MoraesCFSouzaERSouzaVCA common polymorphism in the renin angiotensin system is associated with differential outcome of antihypertensive pharmacotherapy prescribed to Brazilian older womenClin Chim Acta20083961–2707518657531
  • IV Brazilian Guidelines in Arterial Hypertension Work GroupsIV Brazilian guidelines in arterial hypertensionArq Bras Cardiol200482Suppl 4722 Portuguese15107944
  • CockcroftDWGaultMHPrediction of creatinine clearance from serum creatinineNephron197616131411244564
  • FriedewaldWTLevyRIFredricksonDSEstimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifugeClin Chem19721864995024337382
  • International Diabetes FederationIDF Global Guideline for Managing Older People with Type 2 Diabetes Available from: http://www.idf.org/sites/default/files/IDF-Guideline-for-older-people-T2D.pdfAccessed December 11, 2014
  • MionDJrda SilvaGVde GusmãoJLDo Brazilian physicians follow the Brazilian guidelines on hypertension?Arq Bras Cardiol200788221221717384840
  • NóbregaOTFaleirosVPTellesJLGerontology in the developing Brazil: achievements and challenges in public policiesGeriatr Gerontol Int20099213513919740356
  • YuengsrigulAChinTWNussbaumEImmunosuppressive and cytotoxic effects of furosemide on human peripheral blood mononuclear cellsAnn Allergy Asthma Immunol1999836 Pt 155956610619350
  • XuBMakrisAThorntonCOgleRHorvathJSHennessyAAnti-hypertensive drugs clonidine, diazoxide, hydralazine and furosemide regulate the production of cytokines by placentas and peripheral blood mononuclear cells in normal pregnancyJ Hypertens200624591592216612254
  • RolfeMWKunkelSLRowensBStandifordTJCragoeEJJrStrieterRMSuppression of human alveolar macrophage-derived cytokines by amilorideAm J Respir Cell Mol Biol1992665765821591007
  • HaddadJJLandSCAmiloride blockades lipopolysaccharide-induced proinflammatory cytokine biosynthesis in an IkappaB-alpha/NF-kappaB-dependent mechanism. Evidence for the amplification of an antiinflammatory pathway in the alveolar epitheliumAm J Respir Cell Mol Biol200226111412611751211
  • HaddadJJAmiloride and the regulation of NF-kappaB: an unsung crosstalk and missing link between fluid dynamics and oxidative stress-related inflammation – controversy or pseudo-controversy?Biochem Biophys Res Commun2005327237338115629126
  • GavrilovaSADemidovLVMedvedevaNAAshmarinIPChronic administration of interferon-a decreases blood pressure and heart rate in ratsBull Exp Biol Med2000129541341610977936
  • ForseyRJThompsonJMErnerudhJPlasma cytokine profiles in elderly humansMech Ageing Dev2003124448749312714257
  • MaggioMGuralnikJMLongoDLFerrucciLInterleukin-6 in aging and chronic disease: a magnificent pathwayJ Gerontol A Biol Sci Med Sci200661657558416799139
  • DelvesPJRoittIMThe immune system. Second of two partsN Engl J Med2000343210811710891520
  • RoubenoffRHarrisTBAbadLWWilsonPWDallalGEDinarelloCAMonocyte cytokine production in an elderly population: effect of age and inflammationJ Gerontol A Biol Sci Med Sci1998531M20M269467429
  • KrabbeKSPedersenMBruunsgaardHInflammatory mediators in the elderlyExp Gerontol200439568769915130663
  • StarkieROstrowskiSRJauffredSFebbraioMPedersenBKExercise and IL-6 infusion inhibit endotoxin-induced TNF-alpha production in humansFASEB J200317888488612626436
  • PetersenAMPedersenBKThe anti-inflammatory effect of exerciseJ Appl Physiol (1985)20059841154116215772055
  • BruunsgaardHPedersenANSchrollMSkinhojPPedersenBKImpaired production of proinflammatory cytokines in response to lipopolysaccharide (LPS) stimulation in elderly humansClin Exp Immunol1999118223524110540184
  • BonafèMOlivieriFCavalloneLA gender – dependent genetic predisposition to produce high levels of IL-6 is detrimental for longevityEur J Immunol20013182357236111500818
  • KarnikowskiMCórdovaCOliveiraRJKarnikowskiMGNóbrega OdeTNon-alcoholic fatty liver disease and metabolic syndrome in Brazilian middle-aged and older adultsSao Paulo Med J2007125633333718317603
  • EpsteinBJSmithSMChoksiRRecent changes in the landscape of combination RAS blockadeExpert Rev Cardiovasc Ther20097111373138419900020
  • JATOS Study GroupPrincipal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS)Hypertens Res200831122115212719139601
  • SarutaTHayashiKOgiharaTNakaoKFukuiTFukiyamaKCASE-J Study GroupEffects of candesartan and amlodipine on cardiovascular events in hypertensive patients with chronic kidney disease: subanalysis of the CASE-J StudyHypertens Res200932650551219390535
  • OgiharaTFujimotoANakaoKSarutaTCASE-J Trial GroupARB candesartan and CCB amlodipine in hypertensive patients: the CASE-J trialExpert Rev Cardiovasc Ther2008691195120118939907